Tumor-targeting, Systemically Delivered Antisense HER-2 Chemosensitizes Human Breast Cancer Xenografts Irrespective of HER-2 Levels

Overview of attention for article published in Molecular Medicine, August 2002

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (71st percentile)
Above-average Attention Score compared to outputs of the same age and source (57th percentile)

So far, Altmetric has seen 11 patents that reference this research output.

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity, including 7 additional patents.